BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 7515678)

  • 1. AgNOR- and PCNA-studies in astrocytomas of the optic nerve.
    Patt S; Giraldo M; Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):83-7. PubMed ID: 7515678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
    Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
    Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleolar organizer regions (AgNORs) in astrocytic tumors.
    Pedal WP; Warzok RW; Hufnagl P; Roth K
    Zentralbl Pathol; 1994 Mar; 140(1):89-94. PubMed ID: 7515679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohistochemical study on Rosenthal fibers in gliomas using anti-GFAP and anti-ubiquitin antibodies].
    Kobayashi S; Mori H; Ikeuchi S; Takakura K
    No To Shinkei; 1990 Jan; 42(1):59-64. PubMed ID: 1692468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [AgNOR analysis of astrocytoma in childhood].
    Haberland C; Martin H; Guski H; Hufnagl P; Vogel S
    Zentralbl Neurochir; 1996; 57(1):5-11. PubMed ID: 8900893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AgNOR staining may reflect the growth potential of pilocytic astrocytomas.
    Dirven CM; Koudstaal J; Mooij JA; Molenaar WM
    Childs Nerv Syst; 1999 Aug; 15(8):384-8. PubMed ID: 10447607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer].
    Zhao T; Zhang YL; Li CD
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferating cell nuclear antigen, p53 and micro vessel density: Grade II vs. Grade III astrocytoma.
    Malhan P; Husain N; Bhalla S; Gupta RK; Husain M
    Indian J Pathol Microbiol; 2010; 53(1):20-3. PubMed ID: 20090216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical study of the expression of proliferating cell nuclear antigen in astrocytic gliomas of the cerebral hemispheres].
    Korshunov AG; Sycheva RV
    Arkh Patol; 1996; 58(2):32-7. PubMed ID: 8712938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvessel density in brain tumors.
    Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
    Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
    Delahunt B; Bethwaite PB; Nacey JN; Ribas JL
    J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolar organizer regions (NORs) staining and proliferating cell nuclear antigen (PCNA) immunostaining in mucosa-associated lymphoid tissue (MALT) gastric lymphomas.
    Mikou P; Kanavaros P; Aninos D; Tzardi M; Karameris A; Gorgoulis B; Papadopoulos N; Lavergne A; Galian A
    Pathol Res Pract; 1993 Nov; 189(9):1004-9. PubMed ID: 7905623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of anaplastic changes in low-grade astrocytomas of childhood.
    Dirks PB; Jay V; Becker LE; Drake JM; Humphreys RP; Hoffman HJ; Rutka JT
    Neurosurgery; 1994 Jan; 34(1):68-78. PubMed ID: 8121571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature.
    Tchoghandjian A; Fernandez C; Colin C; El Ayachi I; Voutsinos-Porche B; Fina F; Scavarda D; Piercecchi-Marti MD; Intagliata D; Ouafik L; Fraslon-Vanhulle C; Figarella-Branger D
    Brain; 2009 Jun; 132(Pt 6):1523-35. PubMed ID: 19336457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A clinicopathological study of 16 cases with optico-hypothalamic glioma].
    Nitta T; Sato K
    No Shinkei Geka; 1995 Mar; 23(3):217-22. PubMed ID: 7700489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are endothelial cell patterns of astrocytomas indicative of grade?
    Selby DM; Woodard CA; Henry ML; Bernstein JJ
    In Vivo; 1997; 11(5):371-5. PubMed ID: 9427037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
    Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.